Zydus Pharmaceuticals (USA) Inc., a wholly owned subsidiary of Ahmedabad-based Zydus Lifesciences has joined a new coalition of diverse stakeholders to address drug shortages in the United States.

The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare's more pressing and enduring issues, drug shortages that disrupt patient care.

Speaking on the development, Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., said, "Through our innovations and patient-centric approach, we have been committed to providing novel solutions to address unmet healthcare needs of the patients. Providing access to medicines is an important part of our core purpose which is to empower people with the freedom to live healthier and more fulfilled lives. Partnering with diverse stakeholders through this alliance takes us closer to this goal."

The End Drug Shortages Alliance was launched in 2021 to bring together industry stakeholders, including healthcare providers, group purchasing organizations, manufacturers, distributors and other industry thought leaders and champions. The efforts of the alliance focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply.